The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report
Federica Miglietta(University of Padua), Grazia Arpino(University of Naples Federico II), Giuseppe Curigliano(European Institute of Oncology), François‐Clément Bidard(Inserm), Saverio Cinieri(Ospedale A. Perrino), Fabio Puglisi(University of Udine), Umberto Malapelle(Federico II University Hospital), Claudio Zamagni(Policlinico S.Orsola-Malpighi), Aldo Caltavituro(University of Naples Federico II), Daniele Generali(University of Trieste), M. De Laurentis(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Andrea Botticelli(Policlinico Umberto I), Carmine De Angelis(Baylor College of Medicine), Marzia Del Re(Saint Camillus International University of Health and Medical Sciences), Alberto Zambelli, Ida Paris(Agostino Gemelli University Polyclinic), Valentina Guarneri(Istituto Oncologico Veneto), Alessandra Gennari(Ente Ospedaliero Ospedali Galliera), Laura Biganzoli(Hospital of Prato), Giampaolo Bianchini(Vita-Salute San Raffaele University), Lorenzo Gerratana(National Cancer Institute), Mario Giuliano(Regione Campania), Giancarlo Pruneri(University of Milan), Lucia Del Mastro(Ospedale Policlinico San Martino), Carmine Valenza(European Institute of Oncology), Michele Caruso(Humanitas Mater Domini), Maria Grazia Razeti(Ospedale Policlinico San Martino), Luca Malorni(Azienda Usl Toscana Centro), Alessandra Fabi(Agostino Gemelli University Polyclinic), Maria Vittoria Dieci(University of Padua), Matteo Lambertini(Ospedale Policlinico San Martino), Icro Meattini(Azienda Ospedaliero-Universitaria Careggi), Carmen Criscitiello(University of Milan), Sabino De Placido(Federico II University Hospital), Arianna Dri(University of Udine)
Cited by 4
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k